109583-12-2 Usage
General Description
2-Azabicyclo[2.2.2]octane-3-carboxylic acid, also known as 2-Azabicyclo[2.2.2]octane-3-carboxylicacid,(3S)-(9CI), is a chemical compound with the molecular formula C8H13NO2. It is a bicyclic compound containing a seven-membered ring with nitrogen and carbon atoms. This chemical is primarily used in the synthesis of pharmaceuticals and other organic compounds. The (3S) designation in its name indicates that the stereochemistry at the third carbon atom is in the S configuration. It is an important building block in organic synthesis and can be used as a chiral auxiliary in asymmetric synthesis. Its structure and properties make it a valuable compound in the chemical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 109583-12-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,5,8 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 109583-12:
(8*1)+(7*0)+(6*9)+(5*5)+(4*8)+(3*3)+(2*1)+(1*2)=132
132 % 10 = 2
So 109583-12-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H13NO2/c10-8(11)7-5-1-3-6(9-7)4-2-5/h5-7,9H,1-4H2,(H,10,11)
109583-12-2Relevant articles and documents
SATURATED FUSED [1,2-B] PYRIDAZINONE COMPOUNDS
-
Page/Page column 85, (2008/12/06)
The invention is directed to saturated fused [1,2-b]pyridazinone compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
Synthesis and Conformational Studies of Zabicipril (S9650-3), a Potent Inhibitor of Angiotensin Converting Enzyme
Vincent, Michel,Pascard, Claudine,Cesario, Michele,Remond, Georges,Bouchet, Jean-Paul,et al.
, p. 7369 - 7372 (2007/10/02)
The synthesis of the title compound 8c is described.This inhibitor of Angiotensin Converting Enzyme (ACE) contains aza-2 bicyclooctane-carboxylic acid, a bulky cyclic amino acid replacing the proline moiety present in most ACE inhibitors described
